期刊
NATURE MEDICINE
卷 16, 期 10, 页码 1157-U1501出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nm.2216
关键词
-
资金
- Genome Canada
- Genome Quebec
- Emerillon Therapeutics
- Wellcome Trust
- Pfizer
- Medical Research Council (UK)
- Natural Sciences and Engineering Research Council of Canada
- MRC [G0601887] Funding Source: UKRI
- Medical Research Council [G0601887] Funding Source: researchfish
Migraine with aura is a common, debilitating, recurrent headache disorder associated with transient and reversible focal neurological symptoms(1). A role has been suggested for the two-pore domain (K2P) potassium channel, TWIK-related spinal cord potassium channel (TRESK, encoded by KCNK18), in pain pathways and general anaesthesia(2). We therefore examined whether TRESK is involved in migraine by screening the KCNK18 gene in subjects diagnosed with migraine. Here we report a frameshift mutation, F139WfsX24, which segregates perfectly with typical migraine with aura in a large pedigree. We also identified prominent TRESK expression in migraine-salient areas such as the trigeminal ganglion. Functional characterization of this mutation demonstrates that it causes a complete loss of TRESK function and that the mutant subunit suppresses wild-type channel function through a dominant-negative effect, thus explaining the dominant penetrance of this allele. These results therefore support a role for TRESK in the pathogenesis of typical migraine with aura and further support the role of this channel as a potential therapeutic target.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据